<i>MiR-196a2</i> rs11614913 C Allele is Associated with Increased Wilms Tumor Susceptibility in Chinese Children
Wilms tumor, also known as nephroblastoma, is the most common kidney cancer in children. The <i>miR-196a2</i> rs11614913 T>C polymorphism has been identified as a susceptibility locus in various adult cancers. However, it is unclear whether this polymorphism also increases the risk of pediatric cancer. In this study, we examined the genotypes of <i>miR-196a2</i> rs11614913 T>C in 416 pediatric patients with Wilms tumor and 936 age- and gender-matched healthy controls of Chinese Han ethnicity using the TaqMan technology. The association between rs11614913 T>C polymorphism and the susceptibility to Wilms tumor was analyzed by univariable and multivariable logistic regression analyses, and the odds ratio (OR) and 95% confidence interval (CI) were calculated. Overall analysis indicated that the <i>miR-196a2</i> rs11614913 T>C was associated with an increased risk of Wilms tumor in the homozygous (adjusted OR (AOR)=1.58, 95% CI=1.14-2.21, <i>P</i>=0.007), additive (AOR=1.26, 95% CI=1.06-1.49, <i>P</i>=0.007), dominant (AOR=1.33, 95% CI=1.02-1.74, <i>P</i>=0.034), and recessive (AOR=1.38, 95% CI=1.05-1.81, <i>P</i>=0.023) models. Stratification analysis further demonstrated that the association was dependent on age and tumor stages rather than gender. Furthermore, <i>miR-196a2</i> rs11614913 T>C was significantly associated with the disease risk only in children older than 18 months and those with III+IV stage tumors. The expression quantitative trait locus (eQTL) analysis showed that rs11614913 T>C was associated with decreased expression of HOXC-AS1 and increased expression of GPR84 and HOXC8. Our results provide evidence that <i>miR-196a2</i> rs11614913 T>C may confer genetic susceptibility to Wilms tumor. These findings warrant validation in larger cohorts and across different ethnicities.
Authors
- Huimin Yin (ORCID: https://orcid.org/0000-0002-4059-9914)
- Jinhong Zhu (ORCID: https://orcid.org/0000-0002-0408-3101)
- Hongting Lu (ORCID: https://orcid.org/0000-0003-4981-1675)
- Haixia Zhou (ORCID: https://orcid.org/0009-0004-6728-9774)
- Yizhen Wang (ORCID: https://orcid.org/0000-0001-5173-5689)
- Shaohua He
- Ming Luo
- Chunlei Zhou (ORCID: https://orcid.org/0000-0002-0137-3314)
- Jing He (ORCID: https://orcid.org/0009-0002-0404-5276)
- Shouhua Zhang
Institutions
- Qingdao University (CN)
- Fujian Medical University (CN)
- Harbin Medical University (CN)
- Wenzhou Medical University (CN)
- Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University (CN)
- Third Affiliated Hospital of Harbin Medical University (CN)
- Affiliated Hospital of Qingdao University (CN)
- Second Affiliated Hospital of Nanjing Medical University (CN)
- Jiangxi Provincial Children's Hospital (CN)
- Anhui Provincial Children's Hospital (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Journal of Cancer
- Published
- 2024-12-11
- DOI
- https://doi.org/10.7150/jca.102801
- Citations
- 2
- Primary Topic
- Renal and related cancers
- Type
- article
- Field-Weighted Citation Impact
- 0.47
Funders
- Natural Science Foundation of Zhejiang Province